ERBB2 and breast carcinoma: Furthermore, seeding of breast cancer cells on 3D matrix induces drug resistance to both endocrine therapies and HER2 inhibition; this resistance is observed to correlate with enhanced MAPK signaling (Provenzano et al., 2009; Gangadhara et al., 2016).